Advaxis, Inc., (OTCBB: ADXS) (“Advaxis” or the “Company”), a leader in developing the next generation of immunotherapies for cancer and infectious diseases, announced that Daniel J. O’Connor, Senior VP, Chief Legal, and Business Development Officer at Advaxis, will present at the BIO International Convention (BIO 2013) on April 22 at 3:00 p.m. at the McCormick Place Convention Center in Chicago, IL. Mr. O’Connor will provide a review of the progress of the Company’s lead drug candidate, ADXS-HPV. Updated data regarding ADXS-HPV will be disclosed at the 2013 American Society of Clinical Oncology Annual Meeting in June.
